Related references
Note: Only part of the references are listed.T and NK cells: two sides of tumor immunoevasion
Doriana Fruci et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Melanoma Cells Inhibit NK Cell Functions-Letter
Giuseppe Sconocchia et al.
CANCER RESEARCH (2012)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
NK cells sense tumors, course of disease and treatments Consequences for NK-based therapies
Giulia Fregni et al.
ONCOIMMUNOLOGY (2012)
Trial watch Prognostic and predictive value of the immune infiltrate in cancer
Laura Senovilla et al.
ONCOIMMUNOLOGY (2012)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Requirements for control of B-cell lymphoma by NK cells
Christoph D. Brenner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Anti-chemokine small molecule drugs: a promising future?
Amanda E. I. Proudfoot et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
Ronald J. Buckanovich et al.
NATURE MEDICINE (2008)
Adoptive T cell therapy for cancer in the clinic
Carl H. June
JOURNAL OF CLINICAL INVESTIGATION (2007)
Principles of adoptive T cell cancer therapy
Carl H. June
JOURNAL OF CLINICAL INVESTIGATION (2007)
Heparin displaces interferon-γ-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells
Hooman Ranjbaran et al.
CIRCULATION (2006)
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis
Richard A. Colvin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Endothelial cell-T lymphocyte interactions:: iP-10 stimulates rapid transendothelial migration of human effector but not central memory CD4+ T cells.: Requirements for shear stress and adhesion molecules
Thomas D. Manes et al.
TRANSPLANTATION (2006)
Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response
V Milani et al.
INTERNATIONAL IMMUNOLOGY (2005)
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function
RA Colvin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines
AEI Proudfoot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structure-function relationship between the human chemokine receptor CXCR3 and its ligands
I Clark-Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Synergistic effect of adoptive T-cell therapy and intratumoral interferon γ-inducible protein-10 transgene expression in treatment of established tumors
H Huang et al.
CELLULAR IMMUNOLOGY (2002)
CXCR3 internalization following T cell-endothelial cell contact:: Preferential role of IFN-Inducible T cell α chemoattractant (CXCL11)
A Sauty et al.
JOURNAL OF IMMUNOLOGY (2001)
RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium
P von Hundelshausen et al.
CIRCULATION (2001)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Burkitt lymphoma in the mouse
AL Kovalchuk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Tumor angiogenesis factors reduce leukocyte adhesion in vivo
SC Tromp et al.
INTERNATIONAL IMMUNOLOGY (2000)
Ultrastructure and function of the fractalkine mucin domain in CX3C chemokine domain presentation
AM Fong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
